Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Other Working Capital Changes: 2009-2025

Historic Other Working Capital Changes for Gyre Therapeutics (GYRE) over the last 15 years, with Sep 2025 value amounting to -$236,000.

  • Gyre Therapeutics' Other Working Capital Changes rose 40.70% to -$236,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 million, marking a year-over-year decrease of 248.73%. This contributed to the annual value of -$816,000 for FY2024, which is 72.52% down from last year.
  • According to the latest figures from Q3 2025, Gyre Therapeutics' Other Working Capital Changes is -$236,000, which was up 95.94% from -$5.8 million recorded in Q2 2025.
  • Gyre Therapeutics' 5-year Other Working Capital Changes high stood at $5.5 million for Q1 2025, and its period low was -$5.9 million during Q4 2021.
  • Over the past 3 years, Gyre Therapeutics' median Other Working Capital Changes value was $12,174 (recorded in 2023), while the average stood at -$88,802.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first surged by 42,549.31% in 2021, then crashed by 1,004.55% in 2024.
  • Over the past 5 years, Gyre Therapeutics' Other Working Capital Changes (Quarterly) stood at -$5.9 million in 2021, then soared by 87.42% to -$743,000 in 2022, then surged by 141.18% to $306,000 in 2023, then slumped by 949.35% to -$2.6 million in 2024, then skyrocketed by 40.70% to -$236,000 in 2025.
  • Its Other Working Capital Changes stands at -$236,000 for Q3 2025, versus -$5.8 million for Q2 2025 and $5.5 million for Q1 2025.